Needham & Company LLC Reaffirms “Hold” Rating for Docusign (NASDAQ:DOCU)

Posted by Brian Himes on Sep 4th, 2026

Docusign (NASDAQ:DOCU – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & Company LLC in a report released on Friday, Marketbeat Ratings reports.

A number of other equities research analysts also recently weighed in on DOCU. Wedbush lowered their price target on Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Wells Fargo & Company reduced their price objective on Docusign from $60.00 to $55.00 and set an “equal weight” rating on the stock in a research note on Friday, June 5th. Citigroup reaffirmed a “market outperform” rating on shares of Docusign in a report on Tuesday, August 18th. Jefferies Financial Group increased their target price on shares of Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a report on Friday, June 5th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $86.00 price target on shares of Docusign in a research report on Tuesday, August 18th. Four equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $60.60.

Get Our Latest Analysis on Docusign

Docusign Stock Up 0.9%

Shares of NASDAQ:DOCU opened at $65.97 on Friday. The company has a market capitalization of $12.60 billion, a price-to-earnings ratio of 42.84, a price-to-earnings-growth ratio of 2.32 and a beta of 0.90. The company has a 50 day moving average of $55.24 and a two-hundred day moving average of $49.74. Docusign has a 52-week low of $40.16 and a 52-week high of $86.65.

Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping the consensus estimate of $1.09 by $0.07. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business had revenue of $875.75 million for the quarter, compared to analysts’ expectations of $867.22 million. During the same quarter in the previous year, the firm posted $0.30 earnings per share. The company’s revenue was up 9.4% compared to the same quarter last year. On average, equities analysts anticipate that Docusign will post 2.03 earnings per share for the current year.

Insider Activity at Docusign

In related news, insider James Shaughnessy sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $45.54, for a total value of $546,480.00. Following the sale, the insider directly owned 52,815 shares in the company, valued at $2,405,195.10. The trade was a 18.51% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan Thygesen sold 26,250 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total value of $1,208,025.00. Following the completion of the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at $7,318,928.76. This represents a 14.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 90,602 shares of company stock worth $4,323,749. Company insiders own 0.59% of the company’s stock.

Institutional Trading of Docusign

Hedge funds have recently modified their holdings of the business. Corient Private Wealth LP lifted its position in shares of Docusign by 21.0% in the second quarter. Corient Private Wealth LP now owns 287,386 shares of the company’s stock worth $12,766,000 after purchasing an additional 49,898 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Docusign in the second quarter worth $3,247,000. California State Teachers Retirement System boosted its stake in shares of Docusign by 4,016.6% during the 2nd quarter. California State Teachers Retirement System now owns 9,960,652 shares of the company’s stock worth $442,452,000 after acquiring an additional 9,718,686 shares in the last quarter. Ameritas Advisory Services LLC grew its holdings in Docusign by 225.5% during the second quarter. Ameritas Advisory Services LLC now owns 25,109 shares of the company’s stock valued at $1,115,000 after purchasing an additional 17,395 shares during the last quarter. Finally, HB Wealth Management LLC grew its stake in Docusign by 30.0% in the 2nd quarter. HB Wealth Management LLC now owns 11,632 shares of the company’s stock valued at $517,000 after buying an additional 2,687 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.

Key Docusign News

Here are the key news stories impacting Docusign this week:

Positive Sentiment: DocuSign reported fiscal Q2 revenue of $875.7 million, up 9.4% year over year and ahead of the $867.2 million consensus estimate. Adjusted earnings of $1.16 per share also exceeded expectations of approximately $1.08-$1.09. DocuSign fiscal second-quarter results
Positive Sentiment: The company raised its fiscal 2027 revenue, annual recurring revenue (ARR) and IAM-mix outlook. Management cited accelerating adoption of its AI-enabled IAM platform, which uses agreement data to support broader workflow and productivity applications. DocuSign raises forecast on AI momentum
Positive Sentiment: DocuSign expects fiscal Q3 revenue of $886 million to $890 million, broadly around analyst expectations, while full-year revenue guidance is approximately $3.5 billion. The outlook suggests continued stability in the core e-signature business as newer IAM products gain traction.
Positive Sentiment: BTIG Research raised its price target on DOCU from $60 to $75 and upgraded the shares to Buy, adding a favorable analyst signal following the earnings release. BTIG raises DocuSign price target
Neutral Sentiment: Although the earnings and revenue beats were positive, fiscal Q3 revenue guidance was largely in line with consensus rather than materially above it. Investors will likely focus on whether IAM and AI adoption can accelerate growth beyond the current roughly 9% pace.
Positive Sentiment: Separately, consulting firm BearingPoint integrated its GenAIQ tool with DocuSign IAM, potentially expanding use of the platform in procurement and contract-management workflows. BearingPoint integrates GenAIQ with DocuSign IAM

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.